Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FQJNF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,871
Award facts
- Contract value 100% obligated
- $13,870.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for BEYFORTUS 100 mg/ml syringes valued at $13,870.91 on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. BEYFORTUS is a monoclonal antibody immunization indicated for respiratory syncytial virus (RSV) prevention in infants and young children, representing a critical pharmaceutical commodity within the federal medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems globally. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen Drug Corp competes for medical supply requirements through open competitive procurement, demonstrating its capability to fulfill specialized pharmaceutical needs across the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FQJNF?
SPE2DB25FQJNF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FQJNF worth?
The government has obligated $13,871 on SPE2DB25FQJNF.
Is contract SPE2DB25FQJNF an order under another contract?
Yes. SPE2DB25FQJNF is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJNF competed?
The extent of competition for SPE2DB25FQJNF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award